Melanoma epidemiology and trends

Clinics in Dermatology

Volumn 27, Issue 1, 2009, Pages 3-9

  Garbe, Claus ^a   Leiter, Ulrike ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA AND NEW ZEALAND; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STATISTICS; CAUCASIAN; EUROPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SUN EXPOSURE; TUMOR VOLUME; UNITED STATES;

HUMANS; MELANOMA; SKIN NEOPLASMS; SUNLIGHT;

EID: 57449086541     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2008.09.001     Document Type: Article

References (81)

1. Jemal A., Devesa S.S., Hartge P., et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93 (2001) 678-683
2. Garbe C., and Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 14 (2001) 280-290
3. Black R.J., Bray F., Ferlay J., et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33 (1997) 1075-1107
4. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 25 (2000) 459-463
5. Geller A.C., Miller D.R., Annas G.D., et al. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288 (2002) 1719-1720
6. Globocan 2000. Globocan 2000: cancer incidence, mortality and prevalence worldwide. ARC Cancerbase. 5th ed. Vol 1.0 (2001), IARC Press, Lyon
7. Mackie R.M., Hole D., Hunter J.A., et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ 315 (1997) 1117-1121
8. Mansson-Brahme E., Johansson H., Larsson O., et al. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 41 (2003) 138-146
9. de Vries E., Bray F.I., Coebergh J.W., et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 107 (2003) 119-126
10. Anonymus. Stat bite: incidence of and mortality from melanoma of the skin, 1975-2000. J Natl Cancer Inst 95 (2003) 933
11. Robert Koch-Institut. Cancer in Germany 2003-2004. Frequencies and trends (2008), Druckhaus Berlin Mitte, Berlin [German]
12. Bulliard J.L., Cox B., and Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 10 (1999) 407-416
13. Dennis L.K. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135 (1999) 275-280
14. Hall H.I., Miller D.R., Rogers J.D., et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40 (1999) 35-42
15. Marrett L.D., Nguyen H.L., and Armstrong B.K. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 92 (2001) 457-462
16. Osterlind A., Hou-Jensen K., and Moller J.O. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 58 (1988) 385-391
17. Balzi D., Carli P., Giannotti B., et al. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev 12 (2003) 43-48
18. Ocana-Riola R., Martinez-Garcia C., Serrano S., et al. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 17 (2002) 169-174
19. MacLennan R., Green A.C., McLeod G.R., et al. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84 (1992) 1427-1432
20. Jones W.O., Harman C.R., Ng A.K., et al. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 23 (1999) 732-735
21. Balzi D., Carli P., and Geddes M. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries. Cancer Causes Control 8 (1997) 85-92
22. Stang A., Stang K., Stegmaier C., et al. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev 10 (2001) 407-415
23. Bulliard J.L., and Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol 29 (2000) 416-423
24. Insinga R.P., Reither E.N., Remington P.L., et al. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997. WMJ 100 (1902) 27-31
25. Gaudette L.A., Altmayer C.A., Wysocki M., et al. Cancer incidence and mortality across Canada. Health Rep 10 (1998) 51-66
26. Bosetti C., La Vecchia C., Naldi L., et al. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off?. Melanoma Res 14 (2004) 301-309
27. Crocetti E., and Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol 13 (2003) 72-75
28. van der Spek-Keijser L.M., van der Rhee H.J., Toth G., et al. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 136 (1997) 565-571
29. Garbe C., McLeod G.R., and Buettner P.G. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89 (2000) 1269-1278
30. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
31. Balch C.M., Buzaid A.C., Atkins M.B., et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88 (2000) 1484-1491
32. Eigentler T.K., Buettner P.G., Leiter U., et al. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer staging system: an analysis of the German Central Malignant Melanoma Registry. J Clin Oncol 22 (2004) 4376-4383
33. Leiter U., Buettner P.G., Eigentler T.K., et al. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol 22 (2004) 3660-3667
34. Buettner P.G., Leiter U., Eigentler T.K., et al. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 103 (2005) 616-624
35. Buttner P., Garbe C., Bertz J., et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 75 (1995) 2499-2506
36. Garbe C., Buttner P., Bertz J., et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 75 (1995) 2492-2498
37. Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res 160 (2002) 113-121
38. Mackie R.M., Bray C.A., Hole D.J., et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 360 (2002) 587-591
39. Green A., MacLennan R., Youl P., et al. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 53 (1993) 232-236
40. Carli P., Borgognoni L., Biggeri A., et al. Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study. Melanoma Res 4 (1994) 385-390
41. Hoersch B., Leiter U., and Garbe C. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 155 (2006) 771-777
42. Whiteman D.C., Stickley M., Watt P., et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24 (2006) 3172-3177
43. Curtin J.A., Fridlyand J., Kageshita T., et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 353 (2005) 2135-2147
44. Buettner P., Garbe C., and Guggenmoos-Holzmann I. Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol 50 (1997) 1201-1210
45. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
46. Swetter S.M., Soon S., Harrington C.R., et al. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Arch Dermatol 143 (2007) 30-36
47. Richard M.A., Grob J.J., Avril M.F., et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 135 (1999) 269-274
48. Baade P.D., English D.R., Youl P.H., et al. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol 142 (2006) 1422-1427
49. Bono A., Tolomio E., Bartoli C., et al. Metamorphosis of melanoma. Trends in size and thickness of cutaneous melanoma over one decade at the Istituto Nazionale Tumori, Milan. Tumori 94 (2008) 11-13
50. Garbe C., Wiebelt H., and Orfanos C.E. Change of epidemiological characteristics of malignant melanoma during the years 1962-1972 and 1983-1986 in the Federal Republic of Germany. Dermatologica 178 (1989) 131-135
51. Garbe C., and Orfanos C.E. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res Suppl 2 (1992) 285-294
52. Lasithiotakis K., Leiter U., Meier F., et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112 (2008) 1795-1804
53. Jhappan C., Noonan F.P., and Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22 (2003) 3099-3112
54. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41 (2005) 45-60
55. Elwood J.M., and Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 73 (1997) 198-203
56. Garbe C. The sun and malignant melanoma (German language). Hautarzt 43 (1992) 251-257
57. McGovern V.J., and Mackie B.S. The relationship of solar radiation to melanoblastoma. Aust N Z J Surg 28 (1959) 257-262
58. McGovern VJ Epidemiological aspects of melanoma: a review. Pathology 9 (1977) 233-241
59. Dobson A.J., and Leeder S.R. Mortality from malignant melanoma in Australia: effects due to country of birth. Int J Epidemiol 11 (1982) 207-211
60. Longstreth J Cutaneous malignant melanoma and ultraviolet radiation: a review. Cancer Metastasis Rev 7 (1988) 321-333
61. Hinds M.W., and Kolonel L.N. Malignant melanoma of the skin in Hawaii, 1960-1977. Cancer 45 (1980) 811-817
62. Elwood J.M., Gallagher R.P., Hill G.B., et al. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed) 288 (1984) 99-102
63. Osterlind A., Tucker M.A., Stone B.J., et al. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 42 (1988) 319-324
64. Green A., MacLennan R., and Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 35 (1985) 297-300
65. Holly E.A., Kelly J.W., Shpall S.N., et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17 (1987) 459-468
66. Garbe C., Buttner P., Weiss J., et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102 (1994) 695-699
67. Gallagher R.P., McLean D.I., Yang C.P., et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 126 (1990) 770-776
68. Garbe C., Buttner P., Weiss J., et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102 (1994) 700-705
69. Harrison S.L., MacLennan R., Speare R., and Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet 344 (1994) 1529-1532
70. Bauer J., Buttner P., Wiecker T.S., Luther H., and Garbe C. Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1,232 young German children. Int J Cancer 115 (2005) 121-126
71. Wiecker T.S., Luther H., Buettner P., et al. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 97 (2003) 628-638
72. Bauer J., and Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 16 (2003) 297-306
73. Kumar R., Angelini S., Snellman E., et al. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122 (2004) 342-348
74. Pollock P.M., Harper U.L., Hansen K.S., et al. High frequency of BRAF mutations in nevi. Nat Genet 33 (2003) 19-20
75. Yazdi A.S., Palmedo G., Flaig M.J., et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 121 (2003) 1160-1162
76. Gilchrest B.A., Eller M.S., Geller A.C., et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340 (1999) 1341-1348
77. Rieger E., Soyer H.P., Garbe C., et al. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 62 (1995) 393-397
78. Diffey B.L. The future incidence of cutaneous melanoma within the UK. Br J Dermatol 151 (2004) 868-872
79. de Vries E., van de Poll-Franse L.V., Louwman W.J., et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 152 (2005) 481-488
80. Whiteman D.C., Bray C.A., Siskind V., et al. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?. Eur J Cancer Prev 17 (2008) 243-250
81. Lasithiotakis K.G., Leiter U., Gorkievicz R., et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 107 (2006) 1331-1339